• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Prev . Association between COVID-19 morbidity and mortality rates and BCG vaccination policies in OECD countries

tetano

Editor, Senior Moderator
J Infect Prev


. 2021 Mar;22(2):91-93.
doi: 10.1177/1757177420976812. Epub 2020 Dec 4.
Association between COVID-19 morbidity and mortality rates and BCG vaccination policies in OECD countries


Yuki Senoo[SUP] 1 2 [/SUP], Yosuke Suzuki[SUP] 1 3 [/SUP], Kenji Tsuda[SUP] 1 4 [/SUP], Tetsuya Tanimoto[SUP] 1 [/SUP], Kenzo Takahashi[SUP] 1 5 [/SUP]



Affiliations

Abstract

We compared whether the national BCG vaccination (BCGV) policy influenced coronavirus disease 2019 (COVID-19) in Organisation for Economic Co-operation and Development (OECD) countries. Those currently implementing BCGV have a reduced number of COVID-19 morbidity and mortality cases, compared to those who have never implemented a BCGV policy, suggesting the potential protective effect of BCGV against COVID-19.

Keywords: Bacillus Calmette-Guerin vaccine; COVID-19; OECD; coronavirus infections; epidemiology.
 
Back
Top Bottom